Literature DB >> 18999889

Identification of tumor necrosis factor signaling-related proteins during Epstein-Barr virus-induced B cell transformation.

J-P Jeon1, J-W Kim, B Park, H-Y Nam, S-M Shim, M-H Lee, B-G Han.   

Abstract

Epstein-Barr virus (EBV) infection in vitro transforms primary B cells into continuously proliferating lymphoblastoid cell lines (LCLs) that have been widely used as a genomic resource for variety of immunological and genetic studies. However, the biochemical and biological characteristics that distinguish LCLs from the B cells have not been thoroughly investigated. Our proteomic approach showed that EBV infection induced changes in the profiles of tumor necrosis factor (TNF) signaling-related proteins in LCLs including heat shock protein family members TNF receptor-associated protein 1 (TRAP-1), heat shock 70-kDa protein 9 (HSPA9)) and superoxide dismutase 2 (SOD2). In addition, our literature co-occurrence study placed TNF at the center of a gene cluster network of differentially expressed proteins in LCLs. This study suggested that deregulation of TNF signaling pathway could contribute to the cellular transformation and immortalization of the EBV-infected B cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18999889

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  2 in total

1.  Gene expression analysis of whole blood, peripheral blood mononuclear cells, and lymphoblastoid cell lines from the Framingham Heart Study.

Authors:  Roby Joehanes; Andrew D Johnson; Jennifer J Barb; Nalini Raghavachari; Poching Liu; Kimberly A Woodhouse; Christopher J O'Donnell; Peter J Munson; Daniel Levy
Journal:  Physiol Genomics       Date:  2011-11-01       Impact factor: 3.107

2.  Extramedullary nasal plasmacytoma arising after polyp excision and the role of the inflammation in tumor development: A case report.

Authors:  Arianna Di Stadio; Valeria Gambacorta; Stefano de Crescenzo; Angelo Sidoni; Maria Cristina Cristi; Alfredo Di Giovanni; Massimo Maranzano; Giampietro Ricci
Journal:  Mol Clin Oncol       Date:  2020-02-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.